Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis

NCT00195819 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

BIOLOGICAL: adalimumab (D2E7)
BIOLOGICAL: placebo

Sponsor

Abbott